STAAR Surgical Company Income Statement

Financials in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 3, 2026	Jan '26 Jan 2, 2026	Dec '24 Dec 27, 2024	Dec '23 Dec 29, 2023	Dec '22 Dec 30, 2022	Dec '21 Dec 31, 2021
Revenue	339.59	239.44	313.9	322.42	284.39	230.47
Revenue Growth	51.30%	-23.72%	-2.64%	13.37%	23.39%	41.00%
Cost of Revenue	79.39	57.02	74.32	69.76	61.01	51.84
Gross Profit	260.2	182.42	239.58	252.65	223.38	178.64
Selling, General & Admin	180.87	188.31	206.88	184.08	143.6	111.44
Research & Development	38.32	40.06	45.32	40.48	35.98	33.86
Other Operating Expenses	27.28	45.77	-	-	-	-
Total Operating Expenses	246.47	274.13	252.19	224.55	179.58	145.3
Operating Income	13.73	-91.71	-12.61	28.1	43.8	33.34
Interest Income	3.71	4.59	6.42	7.06	3.25	0.98
Other Non-Operating Income (Expense)	-0.06	4.86	-2.86	-1.46	-1.5	-3.01
Total Non-Operating Income (Expense)	3.65	9.45	3.56	5.6	1.75	-2.04
Pretax Income	17.38	-82.26	-9.05	33.7	45.55	31.3
Provision for Income Taxes	13.54	-1.82	11.16	12.35	5.89	3.79
Net Income	3.84	-80.45	-20.21	21.35	39.67	27.51
Net Income to Common	3.84	-80.45	-20.21	21.35	39.67	27.51
Net Income Growth	-	-	-	-46.18%	44.18%	365.26%
Shares Outstanding (Basic)	50	50	49	49	48	47
Shares Outstanding (Diluted)	51	50	49	49	49	49
Shares Change	2.45%	0.90%	-0.61%	0.10%	-0.15%	3.13%
EPS (Basic)	0.07	-1.62	-0.41	0.44	0.83	0.58
EPS (Diluted)	0.07	-1.62	-0.41	0.43	0.80	0.56
EPS Growth	-	-	-	-46.25%	42.86%	366.67%
Free Cash Flow	-6.75	-40.05	-7.67	-3.59	17.61	30.32
Free Cash Flow Growth	-	-	-	-	-41.92%	141.63%
Free Cash Flow Per Share	-0.13	-0.81	-0.16	-0.07	0.36	0.61
Gross Margin	76.62%	76.19%	76.32%	78.36%	78.55%	77.51%
Operating Margin	4.04%	-38.30%	-4.02%	8.71%	15.40%	14.47%
Profit Margin	1.13%	-33.60%	-6.44%	6.62%	13.95%	11.94%
FCF Margin	-1.99%	-16.73%	-2.44%	-1.11%	6.19%	13.15%
EBITDA	23.5	-82.99	-5.72	33.22	48.31	36.98
EBITDA Margin	6.92%	-34.66%	-1.82%	10.30%	16.99%	16.05%
EBIT	13.73	-91.71	-12.61	28.1	43.8	33.34
EBIT Margin	4.04%	-38.30%	-4.02%	8.71%	15.40%	14.47%
Effective Tax Rate	77.91%	2.21%	-123.24%	36.65%	12.92%	12.12%

SEC Filings: 10-K · 10-Q